Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica. 2013 Feb; 98(2):255-63.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 18
Cyclophosphamide
Doxorubicin
Female
Gene Expression Profiling
Genes, myc
Germinal Center
Humans
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Prednisone
Prognosis
Proto-Oncogene Proteins c-bcl-2
Rituximab
Translocation, Genetic
Vincristine
Young Adult

authors with profiles

ROBERTO MIRANDA
L JEFFREY MEDEIROS
KEN HE YOUNG
ZIJUN XU-MONETTE